Sarepta Therapeutics Profit Margin 2006-2021 | SRPT
Current and historical gross margin, operating margin and net profit margin for Sarepta Therapeutics (SRPT) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Sarepta Therapeutics net profit margin as of June 30, 2021 is -105.73%.
|Sarepta Therapeutics Annual Profit Margins
|Sarepta Therapeutics Quarterly Profit Margins
||Medical - Biomedical and Genetics
Sarepta Therapeutics, Inc. focuses on the discovery and development of RNA-based therapeutics for the treatment of rare and infectious diseases. The Company's diverse pipeline includes its lead program eteplirsen, for Duchenne muscular dystrophy. Sarepta Therapeutics, Inc., formerly known as AVI BioPharma, Inc., is headquartered in Bothell, Washington.